Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa(R) Ophthalmic Solution 0.07%
DUBLIN, Jan. 3, 2018 -- (Healthcare Sales &Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Prolensa® (bromfenac opht... Biopharmaceuticals, Generics, Ophthalmology, FDA Perrigo, bromfenac, Prolensa, cataract surgery
Conditions: Epiretinal Membrane; Pseudophakic Cystoid Macular Edema; Irvine-Gass Syndrome; Cataract Intervention: Sponsor: St John of God Hospital, Vienna Completed
Should a terminally ill cancer patient who asks for cataract surgery to improve his quality of life be granted his wish?Medscape Business of Medicine
Should a terminally ill cancer patient who asks for cataract surgery to improve his quality of life be granted his wish?
An 89-year-old woman with history of unremarkable cataract surgery 20 years ago and nonexudative age-related macular degeneration presented with decreased vision. Slit lamp showed an opacity on retroillumination (Fig 1A). Anterior segment (AS) OCT demonstrated fibrotic material with translucent and opacified cystic spaces of varying sizes overlying the anterior surface of the lens (Fig 1B). Visual acuity improved from 20/200 to 20/80 after removal of the fibrosis by anterior vitrectomy. Postoperative AS-OCT confirmed the source of fibrosis as capsular material extending from the posterior iris onto the lens (Fig 1C).
To evaluate differences in postoperative central macular thickness, central macular volume, corrected distance visual acuity (CDVA), and number of intravitreal anti-vascular endothelial growth factor (VEGF) injections between conventional and femtosecond laser –assisted cataract surgery in wet age-related macular degeneration (AMD).
Condition: Failed Conscious Sedation During Procedure Interventions: Drug: remifentanil; Drug: Dexmedetomidine Sponsor: Fundación Universitaria de Ciencias de la Salud Terminated
Conclusion: Ultrasound biomicroscopy was used successfully to classify congenital membranous cataracts prior to surgery. Anterior and posterior capsulorhexis was performed using Klöti RF capsulotomy tips, and capsulectomy was performed using a vitrectomy cutter. These were effective techniques and should be considered for congenital membranous cataract removal surgery. This trial is registered with registration number chiCTR-OOC-17010913. PMID: 29333290 [PubMed]
CONCLUSIONS: IVTA combined with vitrectomy and cataract surgery contributed to inhibit the postoperative inflammation in patients with VH due to PDR. The effect of IVTA in the reduction of diabetic macular oedema may be limited to the early stage after surgery. TRIAL REGISTRATION NUMBER: UMIN000020376, Post-results. PMID: 29343528 [PubMed - as supplied by publisher]
Authors: Accorinti M, Cecere M, Scala A, Pirraglia MP Abstract PURPOSE: To study epidemiology and clinical findings of cataract in HIV+ patients. METHODS: A total of 32 HIV+ patients, 11 with uveitis/retinitis before surgery and 21 without, mean follow-up 44.9 ± 36.6 months, and 114 HIV- patients, 57 with uveitis/retinitis before surgery and 57 without, were retrospectively compared. RESULTS: Visual acuity improved in all HIV+ patients (p
Toric lens implantation in cataract surgery: Automated versus manual horizontal axis marking, analysis of 50 cases. J Fr Ophtalmol. 2018 Jan 10;: Authors: Raucau M, El Chehab H, Agard E, Lagenaite C, Dot C Abstract SUBJECT: The main objective of our study was to evaluate the contribution of automated conjunctival registration in the alignment of toric intraocular lenses by comparing automated registration optimized with Callisto® to manual marking of the horizontal axis. MATERIALS AND METHODS: We performed a prospective, descriptive, monocentric study on patients undergoing cataract surger...